Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a standalone program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for NCA and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program, which takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher that integrates with MedChem Studio and ADMET Predictor. In addition, the company offers MedChem Studio, a software tool for data mining and designing new molecules; and KIWI, a cloud-based cheminformatics platform that provides a secure, integrated, and collaborative environment for project teams to store, search, and share data and models. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies; and regulatory agencies, academic institutions, and non-profit organizations. Simulations Plus, Inc. was founded in 1996 and is headquartered in Lancaster, California.
Highest paying job titles at Simulations Plus, Inc. include Healthcare Director, Medical Director, and Postdoctoral Fellow